The global congenital heart defect devices market is poised for steady growth over the coming years, propelled by rising adoption of minimally invasive procedures, continuous innovation in cardiac device technology, and improving treatment protocols for structural heart abnormalities present from birth. As diagnostic capabilities improve and awareness around pediatric and adult congenital cardiology grows, device…

The bullous pemphigoid market is undergoing a notable transformation as the treatment paradigm shifts from broad immunosuppression toward targeted, mechanism-based biologics. Bullous pemphigoid is a chronic autoimmune subepidermal blistering disorder that predominantly affects elderly patients, arising from an immune attack on basement membrane proteins such as BP180 and BP230. This autoantibody-driven process triggers complement activation…

The vaccine adjuvants market is on a strong upward trajectory, projected to expand at a CAGR of 12.91% between 2024 and 2030. This growth is being fueled by the rising global burden of infectious and cancerous diseases, unmet needs across several vaccine categories, and an ever-growing emphasis on immunization coverage worldwide. As governments, healthcare bodies,…

The surgical sutures market is on a firm growth trajectory, valued at USD 6.03 billion in 2025 and projected to reach USD 11.52 billion by 2034, expanding at a CAGR of 7.57% between 2026 and 2034. This momentum is anchored by rising global surgical volumes, an aging population, growing chronic disease burden, and continuous innovation…

Porphyria is a group of rare inherited or acquired metabolic disorders caused by abnormalities in heme production. Because heme synthesis is a multi-step process occurring in the liver and bone marrow, a disruption at any stage leads to a buildup of porphyrins or their precursors, producing a wide range of clinical symptoms. As diagnostic capabilities…

T-cell immunoreceptor with Ig and ITIM domains, better known as TIGIT, has emerged as one of the most closely watched immune checkpoint targets since the rise of PD-1/PD-L1 blockade. TIGIT is expressed on activated T cells, natural killer cells, and regulatory T cells, and it binds to the ligands CD155 and CD112 found on tumor…

The global pain management devices market is on a strong upward trajectory, projected to grow from USD 5,277.30 million in 2024 to USD 9,350.72 million by 2032, expanding at a CAGR of 7.53% between 2025 and 2032. This growth is fueled by the rising prevalence of chronic pain, an aging global population, frequent product launches,…

Thyroid Eye Disease (TED) is an autoimmune condition affecting the tissues around the eyes, often linked to thyroid dysfunction such as Graves’ disease. Over the past decade, growing awareness of the disorder, along with the arrival of targeted biologic therapies, has reshaped how the condition is treated and monitored. This has, in turn, transformed the…

The neurology devices market is projected to grow at a CAGR of 7.46% between 2024 and 2030, driven by the rising prevalence of brain injuries, dementia, Alzheimer’s disease, and other neurological disorders, alongside a growing geriatric population worldwide. According to the World Health Organization, roughly 55 million people were living with dementia in 2020, while…

The choroidal neovascularization market is witnessing steady momentum as ophthalmology continues to shift from chronic, injection-heavy management toward durable, mechanism-driven therapies. This condition, marked by abnormal blood vessel growth beneath the retina, remains a leading contributor to central vision loss worldwide, particularly among aging populations and individuals with high myopia. With established anti-VEGF agents holding…